N. Depcik-Smith

Peritumoral Fibrosis in Basal Cell and Squamous Cell Carcinoma Mimicking Perineural Invasion: Potential Pitfall in Mohs Micrographic Surgery

F. Flowers, A. Hassanein, S. Proper, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Bacterial contamination of blood products: Factors, options, and insights

M. Brecher, S. Hay, N. Depcik-Smith, 2001, Journal of clinical apheresis.

Phase I T rial o f t he P roteasome I nhibitor P S-341 i n P atients With R efractory H ematologic M alignancies

D. Esseltine, S. Soignet, P. Elliott, 2002 .

Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination

N. Depcik-Smith, Karen P. Gould, J. Casale, 2022, Case reports in dermatological medicine.

Cutaneous Drug Eruption after COVID-19 Vaccination

J. Crane, N. Depcik-Smith, L. Schwartzberg, 2021 .

Peritumoral Fibrosis in Basal Cell and Squamous Cell Carcinoma Mimicking Perineural Invasion: Potential Pitfall in Mohs Micrographic Surgery

F. Flowers, S. Proper, N. Depcik-Smith, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Development and Validation of a Diagnostic 35-Gene Expression Profile Test for Ambiguous or Difficult-to-Diagnose Suspicious Pigmented Skin Lesions

K. Covington, C. Cockerell, P. Gerami, 2020, SKIN The Journal of Cutaneous Medicine.

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.

Beverly S Mitchell, D. Esseltine, S. Soignet, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FETAL SPLENIC RUPTURE FOLLOWING TRANSFUSION

K. Moise, R. Strauss, P. Whitecar, 2001, Obstetrics and gynecology.